Search
Coronary Artery Disease Clinical Trials in United Kingdom
A listing of 29 Coronary Artery Disease clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
25 - 29 of 29
There are currently 29 active clinical trials seeking participants for Coronary Artery Disease research studies. The states with the highest number of trials for Coronary Artery Disease participants are .
Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR Guided Revascularization
Recruiting
The FAST III is a randomized controlled, open-label, multicenter, international, non-inferiority, strategy trial. A total of 2228 participants will be randomized in a 1:1 fashion to either vFFR- or FFR guided revascularization. Patients will be consented prior to the procedure and then followed up to 12 (+1) months after randomization. The primary endpoint is analyzed at 12 months after randomization. Approximately 35 sites in 7 European countries (Netherlands, Ireland, United Kingdom, Germany,... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: Clinique St Martin, Caen, Not set +42 locations
Conditions: Coronary Artery Disease
CT Coronary Angiography for Type 2 Myocardial Infarction
Recruiting
This study is to explore whether a computed tomography (CT) scan of the heart arteries might improve the care of patients that have presented with a suspected Type 2 myocardial infarction (MI). The Investigators hope to demonstrate that these patients may be the ideal group of patients to benefit from cardiac CT scan imaging by; 1. confirming whether they have any disease in their heart arteries 2. demonstrating the severity of the heart artery disease 3. revealing an alternative cause for their... Read More
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
09/26/2023
Locations: Queen Elizabeth University Hospital, Glasgow, Not set
Conditions: Myocardial Infarction, Coronary Artery Disease
iCorMicA - Stratified Medicine in Angina
Recruiting
The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled, parallel-group, end-point trial and registry. The investigators seek to determine whether stratified medical therapy guided by an adjunctive interventional diagnostic procedure (IDP) during the invasive management of patients with known or suspected angina but no obstructive coronary artery disease improves symptoms, wellbeing, cardiovascular risk and clinical outcomes.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/27/2020
Locations: Golden Jubilee National Hospital, Clydebank, Scotland +1 locations
Conditions: Microvascular Angina, Angina, Stable, Ischemia With No Obstructive Coronary Arteries (INOCA), Coronary Microvascular Dysfunction (CMD), Ischaemic Heart Disease, Non-Obstructive Coronary Atherosclerosis, Coronary Artery Disease, Vasospastic Angina, Coronary; Ischemic, Angina Attacks
Leg Ischaemia Management Collaboration
Recruiting
Single-centre prospective cohort study of patients presenting with severe limb ischaemia (SLI). The primary outcome measure will be 12 month major amputation rate. A historical cohort of patients identified retrospectively will be the comparitor group used to assess the impact of a newly-established rapid-access limb salvage clinic.
Primary aim:
- Determine the proportion of patients with SLI undergoing major lower limb amputation within 12 months of presentation.
Secondary aims:
* Assess cl... Read More
Gender:
ALL
Ages:
Between 18 years and 110 years
Trial Updated:
11/03/2020
Locations: Glenfield Hospital Leicester, Leicester, Leicestershire
Conditions: Peripheral Arterial Disease, Critical Limb Ischemia, Frailty, Cognitive Impairment, Coronary Artery Disease
The Prognostic Significance of Fibrosis Detection in Cardiomyopathy
Recruiting
The presence of scar within heart muscle can act as a substrate for abnormal rhythm problems and lead to the developement of heart failure
Clinical significance Correlation with biomarkers and genetic markers
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
04/19/2018
Locations: Royal Brompton Hospital, London, Not set
Conditions: Cardiomyopathy, Coronary Artery Disease
25 - 29 of 29
